Federal regulators, physician groups and medical device manufacturers are wasting little time looking for both quick and long-term fixes to ensure duodenoscopes are properly cleaned and sterilized for reuse. The scramble comes following highly publicized outbreaks of an antibiotic-resistant superbug dubbed CRE (carbapenem-resistant Enterobacteriaceae).
ReWalk Robotics is encountering a few stumbling blocks 6 months after making its NASDAQ debut, with shares taking a hit in light of widening net losses and investor skepticism about the market for its flagship robotic exoskeleton device.
If breathalyzers were installed in every U.S. car, that could save 59,000 lives and $343 million over a 15-year period, according to a University of Michigan study. But while the technology to prevent a person from driving drunk currently is available as an add-on, it's not clear when, or even if, it will become a standard car feature.
InterVene has raised $5.9 million to advance its minimally invasive approach to chronic venous insufficiency. Its catheter-based approach creates new valves out of the patient's native vein wall tissue. If successful, this could offer an innovative curative approach to patients that are often facing long-term management of the condition.
Dermatology outfit Sebacia is touting promising results for its acne-treating technology from two recent clinical studies that show its gold microparticles significantly reduced acne in patients.
Royal Philips plans an IPO for its lighting solutions business during the first half of next year. It's slated to offer only a minority interest in the IPO, which will be followed subsequently by one or more follow-on offerings intended to fully divest Philips.
As the med tech industry turns its attention to devices that can treat and prevent bedsores, a team of GE researchers is developing an innovative handheld probe that can prevent the sores, or pressure ulcers, from forming during hospital stays.
Last June, Auxogyn's Eeva System was the first to be cleared by FDA to aid in IVF embryo selection in combination with traditional morphology. Now the startup has raised $34.3 million, out of a planned $41 million, financing round to start commercializing this test, according to an SEC filing.
Pyramid Education Consultants announced the launch of its new mobile app, PECS IV+, to help autistic people communicate by forming sentence structures with pictures.
The South by Southwest Interactive conference in Austin, TX, is a poor man's version of the grand Consumer Electronics Show in Las Vegas, but it still had a rich array of wearable healthcare-related technology on display during the event's first-ever med tech expo.
Svelte Medical is trying to slenderize the coronary stent. It's raised $16 million to help get to market with its transradial cardiac stent. It has a smaller profile that makes it less invasive and allows it to be inserted via an artery in the wrist rather than the traditional route via the groin.
A jury just cleared a retired, Super Bowl winning wide receiver of charges of fraud related to a plan to pump up the stock of Heart Tronics, a cardiology device company.
Canon U.S.A. just announced its BioMedical subsidiary earlier this month. Now it's made its first med tech deal, an investment in Canadian diagnostic startup Spartan Bioscience, offering a glimpse of what to expect in the future from this new direction for the digital imaging company.
A California-based Boston Scientific company was slapped with a $50 million gender discrimination suit from a former manager and a current executive who claim the devicemaker unfairly favors its male employees by paying them higher salaries and assigning them to more profitable territories.
After staving off Treasury Department rules, angry politicians and antitrust regulators, Medtronic is earning early victories from its $50 billion mega-acquisition of Covidien. The company announced that the former rival's Protégé GPS peripheral stent for treating peripheral artery disease now has the FDA's blessing to be used against lesions in the common and external iliac arteries, located in the pelvis.
The FDA is putting robot assisted surgery in the spotlight this summer.
EnChroma launched a new, indoor version of its color-blindness-correcting glasses for those suffering from red-green color blindness.
Shares of Bovie Medical skidded a further 2% on news that the company had raised about $10.6 million in a follow-on offering. That's an impressive feat given that its market cap is a scant $44 million.
The FDA just labeled the recall of Medtronic's 10 French FlexCath Select Steerable Sheath as a class I recall. This means there is a reasonable probability that the device "will cause serious adverse health consequences or death.
In a win for cardiac ablation device makers like Johnson & Johnson's Biosense Webster and AtriCure, two studies presented at the American College of Cardiology's annual meeting in San Diego concluded that performing atrial fibrillation ablation improves outcomes.